The
victory of the Joe Biden-Kamala Harris ticket in the presidential election
indicates, among other things, a pivotal shift in healthcare policy in the
United States, and in the fight against the pandemic.
Over the
past four years, MHA, national hospital associations, patient advocates, and
other health interests have been forced to fight the current administration
over its policies that have endangered immigrants’ healthcare, the existence of
the Affordable Care Act, state financing of their Medicaid programs,
cost-sharing strategies to enable increased enrollment of the uninsured and
underinsured, and diversity training in hospitals – among many other issues.
Healthcare
interests have also been concerned throughout 2020 about the administration’s
response to the COVID-19 pandemic, especially about its ongoing indifference to
the severity of the threat and the need for basic social distancing.
“MHA and
our members congratulate President-Elect Joe Biden and Vice President-Elect
Kamala Harris on their historic victory,” MHA President & CEO Steve Walsh
said on Saturday, after it became apparent Biden would become the forty-sixth
President of the United States. “With our nation still in the midst of the most
devastating public health crisis in generations, we are confident that their
administration will mount a response that is built around science, the
expertise of medical professionals, and a close partnership with hospitals and
healthcare providers. Our healthcare community is eager to be a resource to the
Biden Administration on the ongoing pandemic, as well as the many other issues
affecting the lives of our patients.”
The Massachusetts hospital community, and the life-sciences sector of which it is an integral part, has proven time and again its ability to help devise advances in medical care, healthcare financing and access innovations, and broad-based coalitions to improve the health of individuals and communities. From all indications based on previous actions and campaign statements, a Biden Administration will be more collaborative – and not opposed – to pen to well-informed suggestions from the medical-science community.